GPAS-Article-Header-EN

Join us this July at the WFH Global Policy and Access Summit (GPAS)

The third edition of the WFH Global Policy and Access Summit (GPAS) will take place from July 6 to 7, 2023. Join your colleagues from patient advocacy associations, healthcare providers, national governments, other collaborating organizations and industry partners to learn, discuss, and exchange knowledge on strategies to alleviate health inequities faced by people living with bleeding disorders across the globe.

Also available in: Français Español

Participants of the two-day virtual WFH Global Policy and Access Summit (GPAS) will experience a rich program with presentations and panel discussions delivered by global experts. Read on to learn more about what you can expect to experience with us this July!

Day one of the Summit will include plenary and educational sessions covering the disparities in access to diagnosis and care for people with bleeding disorders (PWBDs). There will also be dedicated talks on the health inequities faced by people with von Willebrand disease (VWD) and women and girls with bleeding disorders (WGBD) by Nathan Connell, MD (U.S.A), and Dawn Rotellini, WFH Board Member (U.S.A), respectively. The next session will take us on a tour around the world, with WFH national member organizations (NMOs) sharing the successes, challenges and lessons learnt related to their national advocacy projects. The first day of the summit will also feature a panel discussion on strategies to accelerate the identification and diagnosis of PWBD as a first step in accessing care.

Day two of the Summit will feature educational sessions on strengthening the organization of care, with a keynote presentation by Declan Noon, President, European Haemophilia Consortium (EHC) (Ireland) on strategies to increase government investment in bleeding disorders care. Another talk, given by Alok Srivastava, MD (India), will cover the healthcare provider’s perspective on improving care delivery nationally. These insightful presentations will be followed by the government perspective on developing national bleeding disorder programs, with a case study from Brazil.

Another highlight for the second day of the Summit will be a presentation by Glenn Pierce, MD, PhD, Vice President, Medical, WFH (U.S.A), on existing and novel therapies. This will be followed by an expert panel discussion on increasing equitable access to care in our fast-changing treatment landscape. Confirmed expert panelists for this session include Glenn Pierce; Brian O’Mahony (Ireland); Cedric Hermans, MD, Medical Board Member, WFH (Belgium), and David Page (Canada).

The program with continue with a highlight session on the WFH PACT Program and its contribution to increasing access to diagnosis, treatment, and care for PWBD globally. The Summit will close with a dedicated session on the shared decision-making model in healthcare where the new WFH Shared Decision Making Tool for Hemophilia Treatment will be presented to our global community for the very first time.

We look forward to connecting with you virtually this July!

To find out more about the WFH Global Policy and Access Summit (GPAS), please click here.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.